Trials / Completed
CompletedNCT03357887
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
Prognostic Value of Three New Biomarkers of Multiple Sclerosis Compared to Reference Biomarker in Patients With Radiologically Isolated Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Analysis of cerebrospinal fluid and serum | Analysis of biomarkers in patient biological samples |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2017-11-30
- Last updated
- 2025-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03357887. Inclusion in this directory is not an endorsement.